Belgium: Nyxoah launches underwritten public offering in US

Nyxoah, a medical technology company focused on the development of solutions to treat Obstructive Sleep Apnea (OSA), has announced the launch of an underwritten registered public offering of 2.76 million ordinary shares in the US at an assumed public offering price of US$31.46, representing a market cap of US$86.3m. An application has been made to…

You must be a HMI Subscriber to view this content.

Subscribe Now »